A Randomised Double-Blind, Placebo-and-Active-Control, Parallel-arm, Phase III Trial with Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of CG5503 Extended –Release (ER) in Subjects with Moderate to Severe Chronic Low Back Pain.
- Year: 2008
- Type: Pharmaceutical - Pain
- Phase: III
- Indication: Back and/or Leg Pain